Hurwitz Edward
SEC-identified person · CIK 1211840 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Dyne Therapeutics, Inc. DYN | Director | filed 2020–2026 |
| Macrogenics INC MGNX | Director | filed 2013–2026 |
| Applied Genetic Technologies Corp AGTC | Director | filed 2014–2022 |
| Turmeric Acquisition Corp. TMPM | Chief Financial Officer | filed 2020–2020 |
| Tvardi Therapeutics, Inc. TVRD | Director | filed 2014–2014 |
| Viracta Therapeutics, Inc. VIRX | Director | filed 2009–2013 |
| Aegerion Pharmaceuticals, Inc. AEGR | Officer | filed 2010–2012 |
| Threshold Pharmaceuticals INC THLDD | Officer | filed 2008–2009 |
| Torreypines Therapeutics, Inc. TPTX | Officer | filed 2006–2009 |
| Neurogesx Inc NGSX | Officer | filed 2007–2007 |
| Cotherix INC CTRX | Officer | filed 2007–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.